{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:45:10Z","timestamp":1725525910169},"publisher-location":"Dordrecht","reference-count":170,"publisher":"Springer Netherlands","isbn-type":[{"type":"print","value":"9781402097003"},{"type":"electronic","value":"9781402097010"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-1-4020-9701-0_3","type":"book-chapter","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T09:09:01Z","timestamp":1235466541000},"page":"33-63","source":"Crossref","is-referenced-by-count":1,"title":["Oxidative Stress in the Metabolic Syndrome"],"prefix":"10.1007","author":[{"given":"Concei\u00e7\u00e3o","family":"Calhau","sequence":"first","affiliation":[]},{"given":"Alejandro","family":"Santos","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.jhh.1002105","volume":"21","author":"N Abdilla","year":"2007","unstructured":"Abdilla N, Tormo MC, Fabia MJ et al. Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens. 2007; 21: 68\u201375.","journal-title":"J Hum Hypertens"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/01.ATV.0000172689.53992.25","volume":"25","author":"M Adiels","year":"2005","unstructured":"Adiels M, Boren J, Caslake MJ et al. Overproduction of VLDL1 driven by hyperglycaemia is a dominant feature of diabetic dyslipidaemia. Arterioscler Thromb Vasc Biol 2005; 25: 1697\u2013703.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.mol.0000226115.97436.c0","volume":"17","author":"M Adiels","year":"2006","unstructured":"Adiels M, Olofsson SO, Taskinen MR et al. Diabetic dyslipidaemia. Curr Opin Lipidol. 2006; 17: 238\u201346.","journal-title":"Curr Opin Lipidol"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","volume":"28","author":"M Adiels","year":"2008","unstructured":"Adiels M, Olofsson SO, Taskinen MR et al. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidaemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008; 28: 1225\u201336.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","volume":"49","author":"M Adiels","year":"2006","unstructured":"Adiels M, Taskinen MR, Packard C et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006; 49: 755\u201365.","journal-title":"Diabetologia"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s11745-998-0295-6","volume":"33","author":"S Agarwal","year":"1998","unstructured":"Agarwal S, Rao AV. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids. 1998; 33: 981\u20134.","journal-title":"Lipids"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/diabetes.52.5.1210","volume":"52","author":"CM Alexander","year":"2003","unstructured":"Alexander CM, Landsman PB, Teutsch SM et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003; 52: 1210\u20134.","journal-title":"Diabetes"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0008-6363(99)00115-7","volume":"43","author":"PJ Andrew","year":"1999","unstructured":"Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 1999; 43: 521\u201331.","journal-title":"Cardiovasc Res"},{"key":"3_CR9","first-page":"89","volume":"26","author":"S Asgary","year":"2000","unstructured":"Asgary S, Naderi GH, Sarrafzadegan N et al. Antihypertensive and antihyperlipidaemic effects of Achillea wilhelmsii. Drugs Exp Clin Res. 2000; 26: 89\u201393.","journal-title":"Drugs Exp Clin Res"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.54.101601.152409","volume":"54","author":"G Assmann","year":"2003","unstructured":"Assmann G, Nofer JR. Atheroprotective effects of high-density lipoproteins. Annu Rev Med. 2003; 54: 321\u201341.","journal-title":"Annu Rev Med"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.ATV.8.1.79","volume":"8","author":"P Avogaro","year":"1988","unstructured":"Avogaro P, Bon GB, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis. 1988; 8: 79\u201387.","journal-title":"Arteriosclerosis"},{"key":"3_CR12","first-page":"4","volume":"17","author":"JP Bastard","year":"2006","unstructured":"Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006; 17: 4\u201312.","journal-title":"Eur Cytokine Netw"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.48.1.1","volume":"48","author":"JW Baynes","year":"1999","unstructured":"Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999; 48: 1\u20139.","journal-title":"Diabetes"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/01.ATV.20.8.1903","volume":"20","author":"U Bayraktutan","year":"2000","unstructured":"Bayraktutan U, Blayney L, Shah AM. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol. 2000; 20: 1903\u201311.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14779072.6.3.343","volume":"6","author":"HE Bays","year":"2008","unstructured":"Bays HE, Gonz\u00e1lez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008; 6:343\u201368.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","volume":"271","author":"JS Beckman","year":"1996","unstructured":"Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996; 271: C1424\u201337.","journal-title":"Am J Physiol"},{"key":"3_CR17","first-page":"883","volume":"51","author":"J Be\u0142towski","year":"2000","unstructured":"Be\u0142towski J, W\u00f3jcicka G, G\u00f3rny D, Marciniak A. The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol. 2000; 51: 883\u201396.","journal-title":"J Physiol Pharmacol"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"C499","DOI":"10.1152\/ajpcell.00122.2003","volume":"285","author":"YC Boo","year":"2003","unstructured":"Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am J Physiol Cell Physiol. 2003; 285: C499\u2013508.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0891-5849(99)00011-8","volume":"26","author":"V Borcea","year":"1999","unstructured":"Borcea V, Nourooz-Zadeh J, Wolff SP, Klevesath M, Hofmann M, Urich H, Wahl P, Ziegler R, Tritschler H, Halliwell B, Nawroth PP. Alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med. 1999; 26: 1495\u2013500.","journal-title":"Free Radic Biol Med"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.14310\/horm.2002.11182","volume":"5","author":"M Bougoulia","year":"2006","unstructured":"Bougoulia M, Triantos A, Koliakos G. Plasma interleukin-6 levels, glutathione peroxidase and isoprostane in obese women before and after weight loss. Association with cardiovascular risk factors. Hormones. 2006; 5: 192\u2013199.","journal-title":"Hormones"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.yjmcc.2004.04.012","volume":"37","author":"H Cai","year":"2004","unstructured":"Cai H, McNally JS, Weber M et al. Oscillatory shear stress upregulation of endothelial nitric oxide synthase requires intracellular hydrogen peroxide and CaMKII. J Mol Cell Cardiol. 2004; 37: 121\u20135.","journal-title":"J Mol Cell Cardiol"},{"issue":"Suppl 2","key":"3_CR22","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.2337\/diab.46.2.S31","volume":"46","author":"NE Cameron","year":"1997","unstructured":"Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes. 1997; 46 Suppl 2: S31\u20137.","journal-title":"Diabetes"},{"key":"3_CR23","doi-asserted-by":"crossref","unstructured":"Cardona F, T\u00f9nez I, Tasset I, Montilla P, Collantes E, Tinahones FJ. Fat overload aggravates oxidative stress in patients with the metabolic syndrome. Eur J Clin Invest. 2008b; 38:510\u20135.","DOI":"10.1111\/j.1365-2362.2008.01959.x"},{"key":"3_CR24","doi-asserted-by":"crossref","unstructured":"Cardona F, T\u00f9nez I, Tasset I, Murri M, Tinahones FJ. Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridemia with or without the metabolic syndrome. Clin Biochem. 2008a; 41: 701\u20135.","DOI":"10.1016\/j.clinbiochem.2008.03.001"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157339906777950660","volume":"2","author":"CB Chan","year":"2006","unstructured":"Chan CB, Harper ME. Uncoupling proteins: role in insulin resistance and insulin insufficiency. Curr Diabetes Rev. 2006; 2: 271\u201383.","journal-title":"Curr Diabetes Rev"},{"key":"3_CR26","first-page":"31","volume":"25","author":"DC Chan","year":"2004","unstructured":"Chan DC, Barrett PH, Watts GF. Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies. Clin Biochem Rev. 2004; 25: 31\u201348.","journal-title":"Clin Biochem Rev"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/hy09t1.094005","volume":"38","author":"X Chen","year":"2001","unstructured":"Chen X, Touyz RM, Park JB et al. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension. 2001; 38: 606\u201311.","journal-title":"Hypertension"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0165-6147(02)02053-9","volume":"23","author":"JL Cracowski","year":"2002","unstructured":"Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci. 2002; 23: 360\u20136.","journal-title":"Trends Pharmacol Sci"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"F544","DOI":"10.1152\/ajprenal.2000.279.3.F544","volume":"279","author":"KD Croft","year":"2000","unstructured":"Croft KD, McGiff JC, Sanchez-Mendoza A et al. Angiotensin II releases 20-HETE from rat renal microvessels. Am J Physiol Renal Physiol. 2000; 279: F544\u201351.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1021\/bi992902m","volume":"39","author":"LK Curtiss","year":"2000","unstructured":"Curtiss LK, Bonnet DJ, Rye KA. The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. Biochemistry. 2000; 39: 5712\u201321.","journal-title":"Biochemistry"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/14779072.6.5.731","volume":"6","author":"C Cuspidi","year":"2008","unstructured":"Cuspidi C, Sala C, Zanchetti A. Metabolic syndrome and target organ damage: role of blood pressure. Expert Rev Cardiovasc Ther. 2008; 6: 731\u201343.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/01.hjh.0000187259.94448.8a","volume":"23","author":"S Czernichow","year":"2005","unstructured":"Czernichow S, Bertrais S, Blacher J et al. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: association with plasma antioxidant levels. J Hypertens. 2005; 23: 2013\u20138.","journal-title":"J Hypertens"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1210\/jc.2002-021836","volume":"88","author":"P Dandona","year":"2003","unstructured":"Dandona P, Kumar V, Aljada A et al. Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. J Clin Endocrinol Metab. 2003; 88: 4496\u2013501.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR34","first-page":"355","volume":"86","author":"P Dandona","year":"2001","unstructured":"Dandona P, Mohanty P, Ghanim H et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab. 2001; 86: 355\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","volume":"99","author":"G Dav\u00ec","year":"1999","unstructured":"Dav\u00ec G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C.In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999; 99: 224\u20139.","journal-title":"Circulation"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1373\/clinchem.2007.100156","volume":"54","author":"S Ferranti de","year":"2008","unstructured":"de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem. 2008; 54: 945\u201355.","journal-title":"Clin Chem"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2007.08.009","volume":"197","author":"JA Souza de","year":"2008","unstructured":"de Souza JA, Vindis C, Hansel B et al. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. Atherosclerosis. 2008; 197: 84\u201394.","journal-title":"Atherosclerosis"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jcem.87.1.8155","volume":"87","author":"A Dewell","year":"2002","unstructured":"Dewell A, Hollenbeck CB, Bruce B. The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab. 2002; 87: 118\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.HYP.35.6.1270","volume":"35","author":"S Engeli","year":"2000","unstructured":"Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension. 2000; 35: 1270\u20137.","journal-title":"Hypertension"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.52.1.1","volume":"52","author":"JL Evans","year":"2003","unstructured":"Evans JL, Goldfine ID, Maddux BA, Grodsky GM.Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes. 2003; 52: 1\u20138.","journal-title":"Diabetes"},{"issue":"5","key":"3_CR41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2001-0039","volume":"23","author":"JL Evans","year":"2002","unstructured":"Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002; 23(5):599\u2013622.","journal-title":"Endocr Rev"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/15209150050194279","volume":"2","author":"JL Evans","year":"2000","unstructured":"Evans JL, Goldfine ID. Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther. 2000; 2: 401\u201313.","journal-title":"Diabetes Technol Ther"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1089\/ars.2005.7.1040","volume":"7","author":"JL Evans","year":"2005","unstructured":"Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005; 7: 1040\u201352.","journal-title":"Antioxid Redox Signal"},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(02)11403-6","volume":"360","author":"M Ezzati","year":"2002","unstructured":"Ezzati M, Lopez AD, Rodgers A et al. Selected major risk factors and global and regional burden of disease. Lancet. 2002; 360: 1347\u201360.","journal-title":"Lancet"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1161\/01.ATV.12.12.1496","volume":"12","author":"KR Feingold","year":"1992","unstructured":"Feingold KR, Grunfeld C, Pang M et al. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb. 1992; 12: 1496\u2013502.","journal-title":"Arterioscler Thromb"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.RES.88.1.44","volume":"88","author":"I Fleming","year":"2001","unstructured":"Fleming I, Michaelis UR, Bredenkotter D et al. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001; 88: 44\u201351.","journal-title":"Circ Res"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11883-006-0018-8","volume":"8","author":"ES. Ford","year":"2006","unstructured":"Ford ES. Intake and circulating concentrations of antioxidants in metabolic syndrome. Curr Atheroscler Rep. 2006; 8: 448\u201352.","journal-title":"Curr Atheroscler Rep"},{"key":"3_CR48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/157339906776818541","volume":"2","author":"LE Fridlyand","year":"2006","unstructured":"Fridlyand LE, Philipson LH. Reactive species, cellular repair and risk factors in the onset of type 2 diabetes mellitus: review and hypothesis. Curr Diabetes Rev. 2006; 2: 241\u201359.","journal-title":"Curr Diabetes Rev"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1006\/bbrc.1997.6520","volume":"233","author":"B Fuhrman","year":"1997","unstructured":"Fuhrman B, Elis A, Aviram M. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun. 1997; 233: 658\u201362.","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.RES.80.1.45","volume":"80","author":"T Fukui","year":"1997","unstructured":"Fukui T, Ishizaka N, Rajagopalan S et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997; 80: 45\u201351.","journal-title":"Circ Res"},{"key":"3_CR51","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114: 1752\u201361.","journal-title":"J Clin Invest"},{"issue":"1","key":"3_CR52","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1038\/oby.2006.281","volume":"14 Suppl","author":"HN Ginsberg","year":"2006","unstructured":"Ginsberg HN, Zhang YL, Hernandez-Ono A. Metabolic syndrome: focus on dyslipidaemia. Obesity (Silver Spring) 2006; 14 Suppl 1:41S\u20139S.","journal-title":"Obesity (Silver Spring)"},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1194\/jlr.R700007-JLR200","volume":"48","author":"MF Gregor","year":"2007","unstructured":"Gregor MF, Hotamisligil GS. Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res. 2007; 48: 1905\u201314.","journal-title":"J Lipid Res"},{"issue":"2","key":"3_CR54","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.2337\/dc08-s246","volume":"31 Suppl","author":"E. Grossman","year":"2008","unstructured":"Grossman E. Does increased oxidative stress cause hypertension? Diabetes Care. 2008; 31 Suppl 2:S185\u20139.","journal-title":"Diabetes Care"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/S0002-9149(98)00033-2","volume":"81","author":"SM. Grundy","year":"1998","unstructured":"Grundy SM. Hypertriglyceridemia, atherogenic dyslipidaemia, and the metabolic syndrome. Am J Cardiol. 1998; 81: 18B\u201325B.","journal-title":"Am J Cardiol"},{"key":"3_CR56","first-page":"231","volume":"49","author":"R Gupta","year":"2001","unstructured":"Gupta R, Singhal S, Goyle A et al. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. J Assoc Physicians India. 2001; 49: 231\u20135.","journal-title":"J Assoc Physicians India"},{"key":"3_CR57","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1073\/pnas.79.6.1712","volume":"79","author":"ME Haberland","year":"1982","unstructured":"Haberland ME, Fogelman AM, Edwards PA. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci USA. 1982; 79: 1712\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR58","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1016\/S0021-9258(18)90863-X","volume":"259","author":"ME Haberland","year":"1984","unstructured":"Haberland ME, Olch CL, Folgelman AM. Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J Biol Chem. 1984; 259: 11305\u201311.","journal-title":"J Biol Chem"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2004-0305","volume":"89","author":"B Hansel","year":"2004","unstructured":"Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab. 2004; 89: 4963\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2796.2006.01621.x","volume":"259","author":"DG Harrison","year":"2006","unstructured":"Harrison DG, Widder J, Grumbach I et al. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med 2006; 259: 351\u201363.","journal-title":"J Intern Med"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.0000161954.17870.5D","volume":"111","author":"A Harte","year":"2005","unstructured":"Harte A, McTernan P, Chetty R et al. Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. Circulation 2005; 111: 1954\u201361.","journal-title":"Circulation"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.ATV.3.2.149","volume":"3","author":"T Henriksen","year":"1983","unstructured":"Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis. 1983; 3: 149\u201359.","journal-title":"Arteriosclerosis"},{"key":"3_CR63","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1001\/jama.299.19.2287","volume":"299","author":"P Holvoet","year":"2008","unstructured":"Holvoet P, Lee DH, Steffes M et al. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. Jama. 2008; 299: 2287\u201393.","journal-title":"Jama"},{"key":"3_CR64","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.98.15.1487","volume":"98","author":"P Holvoet","year":"1998","unstructured":"Holvoet P, Vanhaecke J, Janssens S et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998; 98: 1487\u201394.","journal-title":"Circulation"},{"key":"3_CR65","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/hy1101.095331","volume":"38","author":"HJ Hong","year":"2001","unstructured":"Hong HJ, Hsiao G, Cheng TH et al. Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension. 2001; 38: 1044\u20138.","journal-title":"Hypertension"},{"key":"3_CR66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0753-3322(96)82629-1","volume":"49","author":"N. Hotta","year":"1995","unstructured":"Hotta N. New approaches for treatment in diabetes: aldose reductase inhibitors. Biomed Pharmacother. 1995; 49: 232\u201343.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3_CR67","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/s001250051422","volume":"40 Suppl","author":"Y Ido","year":"1997","unstructured":"Ido Y, Kilo C, Williamson JR. Cytosolic NADH\/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus. Diabetologia. 1997; 40 Suppl 2: S115\u20137.","journal-title":"Diabetologia"},{"key":"3_CR68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.RES.79.1.32","volume":"79","author":"N Inoue","year":"1996","unstructured":"Inoue N, Ramasamy S, Fukai T et al. Shear stress modulates expression of Cu\/Zn superoxide dismutase in human aortic endothelial cells. Circ Res. 1996; 79: 32\u20137.","journal-title":"Circ Res"},{"key":"3_CR69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s109-1998-8101-y","volume":"76","author":"H Ishii","year":"1998","unstructured":"Ishii H, Koya D, King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med. 1998; 76: 21\u201331.","journal-title":"J Mol Med"},{"key":"3_CR70","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/01.CIR.0000124223.00113.A4","volume":"109","author":"O Jung","year":"2004","unstructured":"Jung O, Schreiber JG, Geiger H et al. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation. 2004; 109: 1795\u2013801.","journal-title":"Circulation"},{"key":"3_CR71","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00125-005-1876-2","volume":"48","author":"R Kahn","year":"2005","unstructured":"Kahn R, Buse J, Ferrannini E et al. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2005; 48: 1684\u201399.","journal-title":"Diabetologia"},{"key":"3_CR72","first-page":"635","volume":"9","author":"K Kedziora-Kornatowska","year":"2004","unstructured":"Kedziora-Kornatowska K, Czuczejko J, Pawluk H et al. The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett. 2004; 9: 635\u201341.","journal-title":"Cell Mol Biol Lett"},{"key":"3_CR73","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0735-1097(01)01615-1","volume":"38","author":"BV Khan","year":"2001","unstructured":"Khan BV, Navalkar S, Khan QA et al. Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease. J Am Coll Cardiol. 2001; 38: 1662\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"3_CR74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","volume":"102","author":"JA Kim","year":"2008","unstructured":"Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008; 102: 401\u201314.","journal-title":"Circ Res"},{"key":"3_CR75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1079\/BJN20031024","volume":"91","author":"MK Kim","year":"2004","unstructured":"Kim MK, Sasaki S, Sasazuki S et al. Long-term vitamin C supplementation has no markedly favourable effect on serum lipids in middle-aged Japanese subjects. Br J Nutr. 2004;91: 81\u201390.","journal-title":"Br J Nutr"},{"key":"3_CR76","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.ATV.0000079011.67194.5A","volume":"23","author":"T Kimura","year":"2003","unstructured":"Kimura T, Sato K, Malchinkhuu E et al. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler Thromb Vasc Biol. 2003; 23: 1283\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cardiores.2005.04.032","volume":"67","author":"G Kojda","year":"2005","unstructured":"Kojda G, Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res. 2005; 67: 187\u201397.","journal-title":"Cardiovasc Res"},{"key":"3_CR78","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/01.HYP.32.5.902","volume":"32","author":"J Laakso","year":"1998","unstructured":"Laakso J, Mervaala E, Himberg JJ et al. Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension. 1998; 32: 902\u20136.","journal-title":"Hypertension"},{"key":"3_CR79","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00004872-199816030-00006","volume":"16","author":"F Lacy","year":"1998","unstructured":"Lacy F, O\u2019Connor DT, Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens. 1998; 16: 291\u2013303.","journal-title":"J Hypertens"},{"key":"3_CR80","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00019501-199809080-00002","volume":"9","author":"B. Lamarche","year":"1998","unstructured":"Lamarche B. Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease. Coron Artery Dis. 1998; 9: 473\u201381.","journal-title":"Coron Artery Dis"},{"key":"3_CR81","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.HYP.0000032100.23772.98","volume":"40","author":"U Landmesser","year":"2002","unstructured":"Landmesser U, Cai H, Dikalov S et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002; 40: 511\u20135.","journal-title":"Hypertension"},{"key":"3_CR82","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI200314172","volume":"111","author":"U Landmesser","year":"2003","unstructured":"Landmesser U, Dikalov S, Price SR et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003; 111:1201\u20139.","journal-title":"J Clin Invest"},{"key":"3_CR83","doi-asserted-by":"crossref","first-page":"R277","DOI":"10.1152\/ajpregu.00758.2002","volume":"285","author":"B Lassegue","year":"2003","unstructured":"Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol. 2003; 285: R277\u201397.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3_CR84","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.103.9.1282","volume":"103","author":"JB Laursen","year":"2001","unstructured":"Laursen JB, Somers M, Kurz S et al. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation. 2001; 103: 1282\u20138.","journal-title":"Circulation"},{"key":"3_CR85","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","volume":"371","author":"CM Lawes","year":"2008","unstructured":"Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371: 1513\u20138.","journal-title":"Lancet"},{"key":"3_CR86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ajh.2007.1","volume":"21","author":"PC Leclerc","year":"2008","unstructured":"Leclerc PC, Proulx CD, Arguin G et al. Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II. Am J Hypertens. 2008; 21: 67\u201371.","journal-title":"Am J Hypertens"},{"key":"3_CR87","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1373\/clinchem.2003.028852","volume":"50","author":"DH Lee","year":"2004","unstructured":"Lee DH, Gross MD, Jacobs DR Jr. Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2004; 50: 582\u20138.","journal-title":"Clin Chem"},{"key":"3_CR88","doi-asserted-by":"crossref","first-page":"19952","DOI":"10.1074\/jbc.M110073200","volume":"277","author":"JM Li","year":"2002","unstructured":"Li JM, Shah AM. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem. 2002; 277: 19952\u201360.","journal-title":"J Biol Chem"},{"key":"3_CR89","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/01.ATV.0000033513.18431.A1","volume":"22","author":"AH Lichtenstein","year":"2002","unstructured":"Lichtenstein AH, Jalbert SM, Adlercreutz H et al. Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol. 2002; 22: 1852\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR90","first-page":"365","volume":"5","author":"TJ Lyons","year":"1997","unstructured":"Lyons TJ, Jenkins AJ. Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Rev. 1997; 5: 365\u2013391.","journal-title":"Diabetes Rev"},{"key":"3_CR91","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1007\/s00125-007-0776-z","volume":"50","author":"JA Maassen","year":"2007","unstructured":"Maassen JA, Romijn JA, Heine RJ. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia. 2007; 50: 2036\u201341.","journal-title":"Diabetologia"},{"key":"3_CR92","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0021-9150(93)90183-U","volume":"104","author":"MI Mackness","year":"1993","unstructured":"Mackness MI, Arrol S, Abbott C et al. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 1993; 104: 129\u201335.","journal-title":"Atherosclerosis"},{"key":"3_CR93","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/archinte.163.12.1448","volume":"163","author":"DJ Maron","year":"2003","unstructured":"Maron DJ, Lu GP, Cai NS et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med. 2003; 163: 1448\u201353.","journal-title":"Arch Intern Med"},{"key":"3_CR94","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ALN.0b013e3181799d45","volume":"109","author":"JA Martyn","year":"2008","unstructured":"Martyn JA, Kaneki M, Yasuhara S. Obesity-induced insulin resistance and hyperglycaemia: etiologic factors and molecular mechanisms. Anesthesiology. 2008; 109: 137\u201348.","journal-title":"Anesthesiology"},{"issue":"4 Pt 1","key":"3_CR95","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.HYP.34.4.539","volume":"34","author":"M McIntyre","year":"1999","unstructured":"McIntyre M, Bohr DF, Dominiczak AF.Endothelial function in hypertension: the role of superoxide anion. Hypertension. 1999; 34 (4 Pt 1): 539\u201345.","journal-title":"Hypertension"},{"key":"3_CR96","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ajcn\/69.2.213","volume":"69","author":"AC Houwelingen van","year":"1999","unstructured":"Mensink RP, van Houwelingen AC, Kromhout D et al. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr. 1999; 69: 213\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"2 Part 2","key":"3_CR97","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.HYP.37.2.414","volume":"37","author":"EM Mervaala","year":"2001","unstructured":"Mervaala EM, Cheng ZJ, Tikkanen I et al. Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes. Hypertension. 2001; 37 (2 Part 2): 414\u20138.","journal-title":"Hypertension"},{"key":"3_CR98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1196\/annals.1331.027","volume":"1031","author":"M. Meydani","year":"2004","unstructured":"Meydani M. Vitamin E modulation of cardiovascular disease. Ann N Y Acad Sci. 2004; 1031:271\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"3_CR99","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000075592","volume":"48","author":"BJ Meyer","year":"2004","unstructured":"Meyer BJ, Larkin TA, Owen AJ et al. Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann Nutr Metab. 2004; 48: 67\u201378.","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"3_CR100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","volume":"142","author":"ER Miller","year":"3rd","unstructured":"Miller ER, 3rd, Pastor-Barriuso R, Dalal D et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005; 142 (1):37\u201346.","journal-title":"Ann Intern Med"},{"issue":"22","key":"3_CR101","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.0000039528.49161.E9","volume":"106","author":"P Minuz","year":"2002","unstructured":"Minuz P, Patrignani P, Gaino S et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation. 2002; 106(22): 2800\u20135.","journal-title":"Circulation"},{"key":"3_CR102","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ajcn\/75.4.767","volume":"75","author":"P Mohanty","year":"2002","unstructured":"Mohanty P, Ghanim H, Hamouda W et al. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr. 2002; 75: 767\u201372.","journal-title":"Am J Clin Nutr"},{"key":"3_CR103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)09328-5","volume":"360","author":"Heart Protection Study Collaborative Group.","year":"2002","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360: 23\u201333.","journal-title":"Lancet"},{"key":"3_CR104","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1073\/pnas.88.22.10045","volume":"88","author":"K Nakazono","year":"1991","unstructured":"Nakazono K, Watanabe N, Matsuno K et al. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA. 1991; 88: 10045\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"37","key":"3_CR105","doi-asserted-by":"crossref","first-page":"34480","DOI":"10.1074\/jbc.M103782200","volume":"276","author":"JR Nofer","year":"2001","unstructured":"Nofer JR, Levkau B, Wolinska I et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem. 2001; 276(37): 34480\u20135.","journal-title":"J Biol Chem"},{"key":"3_CR106","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2337\/diab.44.9.1054","volume":"44","author":"J Nourooz-Zadeh","year":"1995","unstructured":"Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes. 1995; 44: 1054\u20138.","journal-title":"Diabetes"},{"issue":"12 Pt 1-2","key":"3_CR107","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0895-7061(99)00129-6","volume":"12","author":"NN Orie","year":"1999","unstructured":"Orie NN, Zidek W, Tepel M. Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens. 1999; 12(12 Pt 1-2): 1169\u201374.","journal-title":"Am J Hypertens"},{"issue":"3 Pt 2","key":"3_CR108","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.HYP.38.3.655","volume":"38","author":"MC Ortiz","year":"2001","unstructured":"Ortiz MC, Manriquez MC, Romero JC et al. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension. 2001; 38 (3 Pt 2):655\u20139.","journal-title":"Hypertension"},{"key":"3_CR109","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00418354","volume":"39","author":"G Paolisso","year":"1996","unstructured":"Paolisso G, Giugliano D. Oxidative stress and insulin action: is there a relationship? Diabetologia. 1996; 39: 357\u201363.","journal-title":"Diabetologia"},{"issue":"5","key":"3_CR110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbalip.2008.03.002","volume":"1781","author":"S Parthasarathy","year":"2008","unstructured":"Parthasarathy S, Litvinov D, Selvarajan K et al. Lipid peroxidation and decomposition\u2013conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta. 2008; 1781 (5): 221\u201331.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"3_CR111","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.jhh.1001034","volume":"14","author":"J Pedro-Botet","year":"2000","unstructured":"Pedro-Botet J, Covas MI, Martin S et al. Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens. 2000; 14 (6):343\u20135.","journal-title":"J Hum Hypertens"},{"key":"3_CR112","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0029-1211323","volume":"103","author":"A Pfeiffer","year":"1995","unstructured":"Pfeiffer A, Schatz H. Diabetic microvascular complications and growth factors. Exp Clin Endocrinol Diabetes. 1995; 103: 7\u201314.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"3_CR113","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.amjhyper.2006.09.021","volume":"20","author":"Y Plantinga","year":"2007","unstructured":"Plantinga Y, Ghiadoni L, Magagna A et al.Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens. 2007; 20: 392\u20137.","journal-title":"Am J Hypertens"},{"key":"3_CR114","doi-asserted-by":"crossref","unstructured":"Qureshi AA, Qureshi N, Hasler-Rapacz JO et al. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidaemias. Am J Clin Nutr. 1991a; 53 (4 Suppl):1042S\u20136S.","DOI":"10.1093\/ajcn\/53.4.1042S"},{"key":"3_CR115","doi-asserted-by":"crossref","unstructured":"Qureshi AA, Qureshi N, Wright JJ et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr. 1991b; 53(4 Suppl): 1021S\u20136S.","DOI":"10.1093\/ajcn\/53.4.1021S"},{"key":"3_CR116","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI118623","volume":"97","author":"S Rajagopalan","year":"1996","unstructured":"Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 1996; 97: 1916\u201323.","journal-title":"J Clin Invest"},{"key":"3_CR117","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/dmr.5610040702","volume":"4","author":"PJ Randle","year":"1988","unstructured":"Randle PJ, Kerbey AL, Espinal J. Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. Diabetes Metab Rev. 1988; 4: 623\u201338.","journal-title":"Diabetes Metab Rev"},{"key":"3_CR118","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-9120(03)00078-X","volume":"36","author":"S Rashid","year":"2003","unstructured":"Rashid S, Watanabe T, Sakaue T et al. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem. 2003; 36: 421\u20139.","journal-title":"Clin Biochem"},{"key":"3_CR119","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/hh1701.096037","volume":"89","author":"FE Rey","year":"2001","unstructured":"Rey FE, Cifuentes ME, Kiarash A et al. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res. 2001; 89:408\u201314.","journal-title":"Circ Res"},{"key":"3_CR120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12013-007-0026-5","volume":"48","author":"R Robertson","year":"2007","unstructured":"Robertson R, Zhou H, Zhang T, Harmon JS. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys. 2007; 48: 139\u201346.","journal-title":"Cell Biochem Biophys"},{"key":"3_CR121","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00005344-200310000-00001","volume":"42","author":"R Rodrigo","year":"2003","unstructured":"Rodrigo R, Passalacqua W, Araya J et al. Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension. J Cardiovasc Pharmacol. 2003; 42: 453\u201361.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"3_CR122","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/CS20070343","volume":"114","author":"R Rodrigo","year":"2008","unstructured":"Rodrigo R, Prat H, Passalacqua W et al. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin Sci (Lond). 2008; 114 (10):625\u201334.","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"3_CR123","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1291\/hypres.30.1159","volume":"30","author":"R Rodrigo","year":"2007","unstructured":"Rodrigo R, Prat H, Passalacqua W et al. Relationship between oxidative stress and essential hypertension. Hypertens Res. 2007; 30 (12):1159\u201367.","journal-title":"Hypertens Res"},{"issue":"4 Pt 2","key":"3_CR124","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.HYP.34.4.943","volume":"34","author":"JC Romero","year":"1999","unstructured":"Romero JC, Reckelhoff JF. State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999; 34 (4 Pt 2):943\u20139.","journal-title":"Hypertension"},{"issue":"4","key":"3_CR125","first-page":"S3","volume":"8 Suppl","author":"BL. Rosin","year":"2007","unstructured":"Rosin BL. The progression of cardiovascular risk to cardiovascular disease. Rev Cardiovasc Med. 2007; 8 Suppl 4:S3\u20138.","journal-title":"Rev Cardiovasc Med"},{"issue":"10","key":"3_CR126","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2003-030636","volume":"88","author":"FM Sacks","year":"2003","unstructured":"Sacks FM, Campos H. Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab. 2003; 88 (10):4525\u201332.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3_CR127","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.amjhyper.2004.05.022","volume":"17","author":"GT Saez","year":"2004","unstructured":"Saez GT, Tormos C, Giner V et al. Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Am J Hypertens. 2004; 17 (9):809\u201316.","journal-title":"Am J Hypertens"},{"issue":"7","key":"3_CR128","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/01.CIR.0000050626.25057.51","volume":"107","author":"RM Salonen","year":"2003","unstructured":"Salonen RM, Nyyssonen K, Kaikkonen J et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation. 2003; 107 (7):947\u201353.","journal-title":"Circulation"},{"key":"3_CR129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1388-1981(02)00343-8","volume":"1585","author":"R Salvayre","year":"2002","unstructured":"Salvayre R, Auge N, Benoist H et al. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta. 2002; 1585: 213\u201321.","journal-title":"Biochim Biophys Acta"},{"key":"3_CR130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1389200043335603","volume":"5","author":"A Sarkis","year":"2004","unstructured":"Sarkis A, Roman RJ. Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Curr Drug Metab. 2004; 5: 245\u201356.","journal-title":"Curr Drug Metab"},{"key":"3_CR131","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0083-6729(07)76008-9","volume":"76","author":"CK Sen","year":"2007","unstructured":"Sen CK, Khanna S, Rink C et al. Tocotrienols: the emerging face of natural vitamin E. Vitam Horm. 2007; 76:203\u201361.","journal-title":"Vitam Horm"},{"key":"3_CR132","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.RES.0000033523.08033.16","volume":"91","author":"PN Seshiah","year":"2002","unstructured":"Seshiah PN, Weber DS, Rocic P et al. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res. 2002; 91: 406\u201313.","journal-title":"Circ Res"},{"key":"3_CR133","first-page":"198","volume":"8","author":"B Shao","year":"2006","unstructured":"Shao B, Oda MN, Vaisar T et al. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease. Curr Opin Mol Ther. 2006; 8: 198\u2013205.","journal-title":"Curr Opin Mol Ther"},{"key":"3_CR134","first-page":"80","volume":"17","author":"K Sharma","year":"1997","unstructured":"Sharma K, Ziyadeh FN. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol. 1997; 17: 80\u201392.","journal-title":"Semin Nephrol"},{"key":"3_CR135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1024\/0300-9831.73.3.163","volume":"73","author":"F Shidfar","year":"2003","unstructured":"Shidfar F, Keshavarz A, Jallali M et al. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidaemic patients. Int J Vitam Nutr Res. 2003; 73: 163\u201370.","journal-title":"Int J Vitam Nutr Res"},{"key":"3_CR136","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0021-9150(99)00218-X","volume":"148","author":"T Shoji","year":"2000","unstructured":"Shoji T, Nishizawa Y, Fukumoto M et al. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis. 2000; 148: 171\u20137.","journal-title":"Atherosclerosis"},{"key":"3_CR137","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.jhh.1001945","volume":"20","author":"DV Simic","year":"2006","unstructured":"Simic DV, Mimic-Oka J, Pljesa-Ercegovac M et al. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J Hum Hypertens. 2006; 20: 149\u201355.","journal-title":"J Hum Hypertens"},{"key":"3_CR138","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1161\/01.ATV.0000190675.08857.3d","volume":"25","author":"P Sjogren","year":"2005","unstructured":"Sjogren P, Basu S, Rosell M, Silveira A, de Faire U, Vessby B, Hamsten A, Hellenius ML, Fisher RM. Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2005; 25: 2580\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR139","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1515\/CCLM.2008.096","volume":"46","author":"J Skalicky","year":"2008","unstructured":"Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, Palicka V. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med. 2008; 46: 499\u2013505.","journal-title":"Clin Chem Lab Med"},{"key":"3_CR140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s001250051342","volume":"43","author":"DA Slatter","year":"2000","unstructured":"Slatter DA, Bolton CH, Bailey AJ.The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia. 2000; 43: 550\u20137.","journal-title":"Diabetologia"},{"key":"3_CR141","doi-asserted-by":"crossref","first-page":"14D","DOI":"10.1016\/j.amjcard.2008.02.003","volume":"101","author":"SR Steinhubl","year":"2008","unstructured":"Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol. 2008; 101: 14D\u201319D.","journal-title":"Am J Cardiol"},{"key":"3_CR142","doi-asserted-by":"crossref","unstructured":"Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis. 2008 (in press).","DOI":"10.1016\/j.atherosclerosis.2008.06.006"},{"key":"3_CR143","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/01.ATV.17.10.2158","volume":"17","author":"I Suc","year":"1997","unstructured":"Suc I, Escargueil-Blanc I, Troly M et al. HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler Thromb Vasc Biol. 1997; 17: 2158\u201366.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR144","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1006\/bbrc.2000.2877","volume":"272","author":"M Sugano","year":"2000","unstructured":"Sugano M, Tsuchida K, Makino N. High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Biochem Biophys Res Commun. 2000; 272: 872\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR145","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.RES.83.11.1069","volume":"83","author":"CW Sun","year":"1998","unstructured":"Sun CW, Alonso-Galicia M, Taheri MR et al. Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles. Circ Res. 1998; 83: 1069\u201379.","journal-title":"Circ Res"},{"key":"3_CR146","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1073\/pnas.95.8.4754","volume":"95","author":"H Suzuki","year":"1998","unstructured":"Suzuki H, DeLano FA, Parks DA et al. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA. 1998; 95: 4754\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR147","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2337\/diab.46.11.1733","volume":"46","author":"M Tiedge","year":"1997","unstructured":"Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 1997; 46: 1733\u201342.","journal-title":"Diabetes"},{"key":"3_CR148","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","volume":"44","author":"RM. Touyz","year":"2004","unstructured":"Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension. 2004; 44: 248\u201352.","journal-title":"Hypertension"},{"key":"3_CR149","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1210\/jc.2003-030202","volume":"88","author":"H Urakawa","year":"2003","unstructured":"Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 2003; 88: 4673\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.jhh.1001697","volume":"18","author":"H Uzun","year":"2004","unstructured":"Uzun H, Karter Y, Aydin S et al. Oxidative stress in white coat hypertension; role of paraoxonase. J Hum Hypertens. 2004; 18: 523\u20138.","journal-title":"J Hum Hypertens"},{"key":"3_CR151","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.0000057982.50167.6E","volume":"107","author":"J Vakkilainen","year":"2003","unstructured":"Vakkilainen J, Steiner G, Ansquer JC et al. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Circulation. 2003; 107: 1733\u20137.","journal-title":"Circulation"},{"key":"3_CR152","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/S0021-9258(18)52241-9","volume":"266","author":"TJ Berkel Van","year":"1991","unstructured":"Van Berkel TJ, De Rijke YB, Kruijt JK. Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem. 1991; 266: 2282\u20139.","journal-title":"J Biol Chem"},{"key":"3_CR153","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1073\/pnas.95.16.9220","volume":"95","author":"J Vasquez-Vivar","year":"1998","unstructured":"Vasquez-Vivar J, Kalyanaraman B, Martasek P et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA. 1998; 95: 9220\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3_CR154","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.HYP.36.6.957","volume":"36","author":"ND Vaziri","year":"2000","unstructured":"Vaziri ND, Ni Z, Oveisi F et al. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension. 2000; 36 (6):957\u201364.","journal-title":"Hypertension"},{"issue":"1","key":"3_CR155","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1185\/030079905X36468","volume":"21 Suppl","author":"B. Verges","year":"2005","unstructured":"Verges B. Diabetic dyslipidaemia: insights for optimizing patient management. Curr Med Res Opin. 2005; 21 Suppl 1: S29\u201340.","journal-title":"Curr Med Res Opin"},{"key":"3_CR156","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1161\/01.CIR.0000147614.85888.7A","volume":"110","author":"W Verreth","year":"2004","unstructured":"Verreth W, De Keyzer D, Pelat M et al. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Circulation. 2004; 110: 3259\u201369.","journal-title":"Circulation"},{"key":"3_CR157","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.ijo.0803177","volume":"30","author":"HK Vincent","year":"2006","unstructured":"Vincent HK, Taylor AG.Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond). 2006; 30: 400\u201318.","journal-title":"Int J Obes (Lond)"},{"key":"3_CR158","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/jn\/138.6.1179","volume":"138","author":"F Violi","year":"2008","unstructured":"Violi F, Cangemi R. Statin treatment as a confounding factor in human trials with vitamin E. J Nutr. 2008; 138: 1179\u201381.","journal-title":"J Nutr"},{"issue":"Suppl 2","key":"3_CR159","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/diab.46.2.S19","volume":"46","author":"H. Vlassara","year":"1997","unstructured":"Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes. 1997; 46 Suppl 2: S19\u201325.","journal-title":"Diabetes"},{"key":"3_CR160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ajcn\/73.2.225","volume":"73","author":"KE Wangen","year":"2001","unstructured":"Wangen KE, Duncan AM, Xu X et al. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr. 2001; 73: 225\u201331.","journal-title":"Am J Clin Nutr"},{"key":"3_CR161","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.freeradbiomed.2004.12.024","volume":"38","author":"NC Ward","year":"2005","unstructured":"Ward NC, Puddey IB, Hodgson JM et al. Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. Free Radic Biol Med. 2005; 38: 1032\u20136.","journal-title":"Free Radic Biol Med"},{"key":"3_CR162","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.CIR.0000136808.72912.D9","volume":"110","author":"NC Ward","year":"2004","unstructured":"Ward NC, Rivera J, Hodgson J et al. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation. 2004; 110: 438\u201343.","journal-title":"Circulation"},{"key":"3_CR163","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.hjh.0000254373.96111.43","volume":"25","author":"NC Ward","year":"2007","unstructured":"Ward NC, Wu JH, Clarke MW et al. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens. 2007; 25: 227\u201334.","journal-title":"J Hypertens"},{"key":"3_CR164","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/hq0202.104081","volume":"22","author":"S Wassmann","year":"2002","unstructured":"Wassmann S, Laufs U, Muller K et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2002; 22: 300\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR165","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/BF02537079","volume":"28","author":"T Watkins","year":"1993","unstructured":"Watkins T, Lenz P, Gapor A et al. gamma-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids. 1993; 28: 1113\u20138.","journal-title":"Lipids"},{"key":"3_CR166","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ajcn\/83.1.30","volume":"83","author":"T Weinbrenner","year":"2006","unstructured":"Weinbrenner T, Schroder H, Escurriol V et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr. 2006; 83: 30\u20135; quiz 181\u20132.","journal-title":"Am J Clin Nutr"},{"key":"3_CR167","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/hy0302.104670","volume":"39","author":"K Yasunari","year":"2002","unstructured":"Yasunari K, Maeda K, Nakamura M et al. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension. 2002; 39: 777\u201380.","journal-title":"Hypertension"},{"key":"3_CR168","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1042\/bst0311062","volume":"31","author":"IS Young","year":"2003","unstructured":"Young IS, McFarlane C, McEneny J. Oxidative modification of triacylglycerol-rich lipoproteins. Biochem Soc Trans. 2003; 31:1062\u20135.","journal-title":"Biochem Soc Trans"},{"key":"3_CR169","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/hy1201.099611","volume":"38","author":"G Zalba","year":"2001","unstructured":"Zalba G, San Jose G, Moreno MU et al. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension. 2001; 38: 1395\u20139.","journal-title":"Hypertension"},{"key":"3_CR170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","volume":"114","author":"L Zheng","year":"2004","unstructured":"Zheng L, Nukuna B, Brennan ML et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest. 2004; 114: 529\u201341.","journal-title":"J Clin Invest"}],"container-title":["Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4020-9701-0_3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T03:29:02Z","timestamp":1633145342000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4020-9701-0_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9781402097003","9781402097010"],"references-count":170,"URL":"https:\/\/doi.org\/10.1007\/978-1-4020-9701-0_3","relation":{},"subject":[]}}